FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109486547> ?p ?o ?g. }

• W2109486547 endingPage "1185" @default.
• W2109486547 startingPage "1169" @default.
• W2109486547 abstract "Pantoprazole is a new proton pump inhibitor indicated for the treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD) and is available in both oral and intravenous (IV) formulations.This paper reviews the pharmacologic properties of pantoprazole and summarizes the findings from clinical studies of this drug.This review was compiled from the published literature, abstracts from clinical trials, and data on file with the manufacturer of pantoprazole.Pantoprazole selectively accumulates in the acidic environment of gastric parietal cells and acts at the final step of acid secretion by binding 2 key cysteine residues of the proton pump involved in gastric acid production. The bioavailability of pantoprazole is not altered by concomitant administration of food or antacids or with repeated dosing. Both oral and IV formulations of pantoprazole exhibit linear pharmacokinetics. Several clinical trials have proved pantoprazole superior to histamine-2-receptor antagonists (H2RAs) in reducing acid secretion and elevating gastric pH levels. Pantoprazole has been shown to be more effective than ranitidine (P < 0.05), famotidine (P < 0.001), and nizatidine (P < 0.05), and at least as effective as omeprazole, in healing erosive esophagitis and relieving associated symptoms of GERD, including regurgitation. Pantoprazole is also more effective than the H2RA nizatidine for the treatment of nighttime heartburn (P < 0.05). Studies have shown pantoprazole to be well tolerated; adverse events, including headache, diarrhea, flatulence, abdominal pain, eructation, nausea, and rash, occurred in < or = 6% of patients. The oral and IV formulations of pantoprazole are equally potent in inhibiting gastric acid secretion; thus, switching between formulations requires no dosage adjustments. Special patient populations, including the elderly and patients with renal or mild to moderate hepatic impairment, can take pantoprazole without an adjustment in dosage.Because of its unique pharmacokinetic properties, mechanism of action, and reduced potential for producing cytochrome P-450-based drug interactions, pantoprazole in both oral and IV formulations is effective over a full 24 hours and is well tolerated in a variety of patient types." @default.
• W2109486547 created "2016-06-24" @default.
• W2109486547 creator A5016226774 @default.
• W2109486547 date "2000-10-01" @default.
• W2109486547 modified "2023-09-27" @default.
• W2109486547 title "Clinical experience with pantoprazole in gastroesophageal reflux disease" @default.
• W2109486547 cites W1558946738 @default.
• W2109486547 cites W1658956668 @default.
• W2109486547 cites W1971393118 @default.
• W2109486547 cites W1979900025 @default.
• W2109486547 cites W1985636157 @default.
• W2109486547 cites W1987195250 @default.
• W2109486547 cites W1987333597 @default.
• W2109486547 cites W1987994512 @default.
• W2109486547 cites W1990398643 @default.
• W2109486547 cites W1991626196 @default.
• W2109486547 cites W1994819357 @default.
• W2109486547 cites W1997352482 @default.
• W2109486547 cites W1997760722 @default.
• W2109486547 cites W1998263670 @default.
• W2109486547 cites W1998652701 @default.
• W2109486547 cites W2008144286 @default.
• W2109486547 cites W2009354071 @default.
• W2109486547 cites W2010769911 @default.
• W2109486547 cites W2016711638 @default.
• W2109486547 cites W2016891497 @default.
• W2109486547 cites W2018374452 @default.
• W2109486547 cites W2019327551 @default.
• W2109486547 cites W2024697584 @default.
• W2109486547 cites W2028912886 @default.
• W2109486547 cites W2034385488 @default.
• W2109486547 cites W2041090677 @default.
• W2109486547 cites W2041830516 @default.
• W2109486547 cites W2042960480 @default.
• W2109486547 cites W2053335124 @default.
• W2109486547 cites W2054043254 @default.
• W2109486547 cites W2054762708 @default.
• W2109486547 cites W2060313173 @default.
• W2109486547 cites W2063448572 @default.
• W2109486547 cites W2064972305 @default.
• W2109486547 cites W2067684321 @default.
• W2109486547 cites W2072615042 @default.
• W2109486547 cites W2075200277 @default.
• W2109486547 cites W2087725068 @default.
• W2109486547 cites W2088018698 @default.
• W2109486547 cites W2089454236 @default.
• W2109486547 cites W2118308986 @default.
• W2109486547 cites W2118578781 @default.
• W2109486547 cites W2126705325 @default.
• W2109486547 cites W2314540303 @default.
• W2109486547 cites W3190539836 @default.
• W2109486547 cites W4237736006 @default.
• W2109486547 cites W4251304310 @default.
• W2109486547 cites W4255683556 @default.
• W2109486547 cites W4321508282 @default.
• W2109486547 doi "https://doi.org/10.1016/s0149-2918(00)83061-1" @default.
• W2109486547 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11110229" @default.
• W2109486547 hasPublicationYear "2000" @default.
• W2109486547 type Work @default.
• W2109486547 sameAs 2109486547 @default.
• W2109486547 citedByCount "25" @default.
• W2109486547 countsByYear W21094865472013 @default.
• W2109486547 countsByYear W21094865472015 @default.
• W2109486547 countsByYear W21094865472017 @default.
• W2109486547 countsByYear W21094865472022 @default.
• W2109486547 countsByYear W21094865472023 @default.
• W2109486547 crossrefType "journal-article" @default.
• W2109486547 hasAuthorship W2109486547A5016226774 @default.
• W2109486547 hasConcept C126322002 @default.
• W2109486547 hasConcept C2776462128 @default.
• W2109486547 hasConcept C2777014526 @default.
• W2109486547 hasConcept C2777445857 @default.
• W2109486547 hasConcept C2777498785 @default.
• W2109486547 hasConcept C2777504413 @default.
• W2109486547 hasConcept C2779134260 @default.
• W2109486547 hasConcept C2779422922 @default.
• W2109486547 hasConcept C2781025758 @default.
• W2109486547 hasConcept C2781263782 @default.
• W2109486547 hasConcept C2781315423 @default.
• W2109486547 hasConcept C43270747 @default.
• W2109486547 hasConcept C71924100 @default.
• W2109486547 hasConcept C90924648 @default.
• W2109486547 hasConcept C98274493 @default.
• W2109486547 hasConceptScore W2109486547C126322002 @default.
• W2109486547 hasConceptScore W2109486547C2776462128 @default.
• W2109486547 hasConceptScore W2109486547C2777014526 @default.
• W2109486547 hasConceptScore W2109486547C2777445857 @default.
• W2109486547 hasConceptScore W2109486547C2777498785 @default.
• W2109486547 hasConceptScore W2109486547C2777504413 @default.
• W2109486547 hasConceptScore W2109486547C2779134260 @default.
• W2109486547 hasConceptScore W2109486547C2779422922 @default.
• W2109486547 hasConceptScore W2109486547C2781025758 @default.
• W2109486547 hasConceptScore W2109486547C2781263782 @default.
• W2109486547 hasConceptScore W2109486547C2781315423 @default.
• W2109486547 hasConceptScore W2109486547C43270747 @default.
• W2109486547 hasConceptScore W2109486547C71924100 @default.
• W2109486547 hasConceptScore W2109486547C90924648 @default.
• W2109486547 hasConceptScore W2109486547C98274493 @default.

• next